Davy Research

DSM (DSMN.AS, DSM NA)

  • 16491.5
  • 181.4
  • 96.3

Company Profile

DSM is one of the world's largest B2B nutrition companies; it also has diverse interests in speciality chemicals, biotech and pharma. Its business scope spans life sciences (Nutrition, Food Specialities, Personal Care) and material sciences (Polymer Intermediates, Performance Materials). It also has several emerging business areas (primarily biotech-related), which it clusters together in its Innovation Center division.


Major Shareholders%
UBS 4.5
DSM 3.7
Blackrock 3.0
The Capital Group Companies 2.8
Norges Bank 2.7
  • DSM

    Closing Price (c): 9090.0

  • RATING 11/02/15

  • PREVIOUS RATING 16/07/14

    NEUTRAL

Analyst(S)

COMPANY DATA

UPCOMING EVENTS

  • There are no upcomming events at present